# A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream

> **NCT05514353** · PHASE1 · COMPLETED · sponsor: **Pyramid Biosciences** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers
- Psoriasis

## Interventions

- **DRUG:** PBI-100 Topical Cream
- **DRUG:** Vehicle Cream

## Key facts

- **NCT ID:** NCT05514353
- **Lead sponsor:** Pyramid Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-28
- **Primary completion:** 2023-01-12
- **Final completion:** 2023-01-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05514353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05514353, "A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05514353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*